Polen Capital Management
IRMD icon

Polen Capital Management’s iRadimed IRMD Stock Holding History

Polen Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-20,744
Closed -$2M – 251
2026
Q1 		$2M Sell
20,744
-6,147
-23% -$615K 0.01% 101
2025
Q4 		$2.62M Sell
26,891
-1,568
-6% -$135K 0.01% 77
2025
Q3 		$2.03M Buy
28,459
+3,570
+14% +$238K 0.01% 96
2025
Q2 		$1.49M Buy
+24,889
New +$1.36M ﹤0.01% 105

Other funds holding IRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
CCM
Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $321M AUM 44.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Polen Capital Management's IRMD Position: Q2 2026 in Review

Polen Capital Management sold out of iRadimed (IRMD) in Q2 2026, closing a stake of 20,744 shares — an estimated $2M sold.

Polen Capital Management first reported a position in IRMD in Q2 2025 and held it in 4 quarters. The position peaked at $2.62M in Q4 2025. 213 funds tracked by Wall St. Rank hold IRMD as of Q2 2026.

  • Polen Capital Management reported no remaining iRadimed position as of Q2 2026 after selling out during the quarter.
  • Polen Capital Management sold 20,744 iRadimed shares in Q2 2026, an estimated $2M.
  • Polen Capital Management first reported a position in iRadimed in Q2 2025 and held it in 4 quarters.
  • Polen Capital Management's iRadimed position peaked at $2.62M in Q4 2025.
  • 213 funds tracked by Wall St. Rank held iRadimed as of Q2 2026.

Based on Polen Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.